Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Hepatology · Biliary Atresia

Why Is Ursodiol Used for Biliary Atresia After Kasai?

At a Glance

After the Kasai procedure for biliary atresia, ursodiol may support bile flow and protect liver cells while a baby heals. It may improve jaundice, but it does not replace surgery or guarantee that liver scarring or a transplant will be avoided.

Caring for a baby who has just had a Kasai procedure is exhausting and often frightening. As you manage your baby’s recovery, you may wonder why they need to take a daily medication called Ursodiol (ursodeoxycholic acid or UDCA). Ursodiol is a manufactured version of a naturally occurring bile acid. While it is generally well-tolerated when prescribed, no medication is entirely risk-free.

In infants with biliary atresia, Ursodiol is often prescribed “off-label” as supportive care. It does not replace the surgery or guarantee the liver will fully recover, but it may help support bile flow and improve laboratory tests while your baby heals [1].

How Ursodiol Works

In biliary atresia, the main bile ducts outside the liver are blocked or absent, causing bile to back up and injure liver cells. The Kasai procedure (portoenterostomy) connects a piece of the intestine directly to the base of the liver (the porta hepatis) so that remaining microscopic bile ducts inside the liver can drain.

Ursodiol is used to support this delicate new drainage system in two possible ways:

  • Changing bile composition: Natural bile can be harsh and damaging to liver cells when it builds up. Ursodiol replaces some of these toxic natural bile acids with a gentler version [2]. This is believed to help protect the liver cells from injury while the microscopic ducts adapt [1][2].
  • Stimulating bile flow: It has a “choleretic” effect, meaning it encourages the liver to secrete more bile fluid [1]. This may help keep bile moving through the residual microscopic ducts into the intestine [3].

What the Research Shows

Doctors often prescribe Ursodiol based on clinical experience and studies that show it can be helpful, though practices vary between different liver centers [4][5].

  • Clearing jaundice: Observational studies suggest that infants who take Ursodiol in the first year after surgery often have lower bilirubin (a yellow pigment in the blood) and clear their jaundice faster [6][7].
  • What is still uncertain: While Ursodiol is associated with improved lab results, there is no definitive proof that it prevents long-term liver scarring (fibrosis) or guarantees a child will avoid needing a liver transplant [6][8]. It is a helpful tool, but not a cure.

Dosing and Practical Administration

Your hepatology (liver) team will calculate a precise dose based on your baby’s weight, which will need to be adjusted as they grow [6].

  • Giving the medicine: Ursodiol for infants is usually a liquid suspension. Always use an oral syringe (never a household spoon) for accuracy. Shake the bottle well before every dose. If you miss a dose or your baby vomits it up, do not double the next dose—ask your care team for their specific instructions.
  • How long to take it: There is no universal stopping date. Some babies take it for a few months; others take it for a year or more [4][6]. Your doctor will look at the whole clinical picture—including bilirubin, liver enzymes, growth, and stool color—to decide when it is safe to stop.

Side Effects and Post-Kasai Warning Signs

Ursodiol is generally safe, with mild gastrointestinal issues (like loose stools or diarrhea) being the most common side effect [9].

Important Warning: Do not assume diarrhea, vomiting, or fussiness are just medication side effects. Babies who have had a Kasai procedure are at high risk for cholangitis (a serious infection of the bile ducts) and blocked bile flow.

Call your care team or seek immediate medical help if your baby has:

  • A fever
  • Pale, white, or clay-colored stools (a sign bile is not draining)
  • Worsening jaundice (more yellowing of the skin or eyes)
  • Dark urine
  • Persistent vomiting, poor feeding, or dehydration (fewer wet diapers)
  • Unusual sleepiness or lethargy

Always give Ursodiol exactly as prescribed, and never stop or change the dose without talking to your hepatology team.

Common questions in this guide

Why do babies with biliary atresia take ursodiol after a Kasai procedure?
Ursodiol may help bile flow through the tiny ducts that remain after the Kasai procedure and may make bile less irritating to liver cells. It may help the yellowing of the skin and eyes clear sooner in some infants, but it does not replace surgery or cure biliary atresia.
How do I give liquid ursodiol safely to my baby?
Use the dose and liquid concentration prescribed by the hepatology team, and measure it with an oral syringe rather than a household spoon. Shake the bottle well if it is a suspension, and expect the dose to be adjusted as your baby gains weight.
What if my baby spits up or misses an ursodiol dose?
Do not give a double dose to make up for a missed dose or one your baby vomited. Ask your care team what to do for your baby's specific medicine and timing, especially if vomiting continues or your baby cannot keep feeds or medicines down.
How long will my baby need ursodiol after Kasai surgery?
There is no standard stopping date. Some infants take ursodiol for a few months, while others need it for a year or longer; the doctor considers bile pigment levels, liver tests, growth, and stool color before changing or stopping it.
What are common ursodiol side effects in infants?
Loose stools or diarrhea are the most common mild side effects described with ursodiol. However, diarrhea, vomiting, or fussiness after a Kasai procedure should not automatically be blamed on the medicine because they can occur with infection or blocked bile flow.
Which warning signs after the Kasai procedure need urgent medical attention?
Call the care team promptly or seek immediate medical help for fever, pale or clay-colored stools, worsening jaundice, dark urine, persistent vomiting, poor feeding, fewer wet diapers, or unusual sleepiness. These signs can indicate cholangitis or blocked bile flow and should not be watched at home without medical guidance.

Get notified when new evidence is published on Isolated biliary atresia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Bile Acids as Signaling Molecules: Role of Ursodeoxycholic Acid in Cholestatic Liver Disease.

    Cifuentes-Silva E, Cabello-Verrugio C

    Current protein & peptide science 2024; (25(3)):206-214 doi:10.2174/1389203724666230818092800.

    PMID: 37594109
  2. 2

    Periductal bile acid exposure causes cholangiocyte injury and fibrosis.

    Dotan M, Fried S, Har-Zahav A, et al.

    PloS one 2022; (17(3)):e0265418 doi:10.1371/journal.pone.0265418.

    PMID: 35294492
  3. 3

    Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?

    Davenport M

    Pediatric surgery international 2017; (33(12)):1263-1273 doi:10.1007/s00383-017-4157-5.

    PMID: 28940004
  4. 4

    Delphi Method Analysis and Consensus of Prevalent Distinctive Practices for Biliary Atresia Management after Kasai Portoenterostomy.

    Vutukuru S, Solanki S, Kanojia RP

    Journal of Indian Association of Pediatric Surgeons 2024; (29(3)):271-276 doi:10.4103/jiaps.jiaps_250_23.

    PMID: 38912031
  5. 5

    Adjuvant treatments for biliary atresia.

    Burns J, Davenport M

    Translational pediatrics 2020; (9(3)):253-265 doi:10.21037/tp.2016.10.08.

    PMID: 32775244
  6. 6

    Dosage and duration of ursodeoxycholic acid therapy Post-Kasai portoenterostomy in biliary atresia: a multicenter cross-sectional study with age stratification.

    Meng Y, Liu S, Yang Q, et al.

    Pediatric surgery international 2025; (41(1)):279 doi:10.1007/s00383-025-06180-x.

    PMID: 40884601
  7. 7

    Effect of combined ursodeoxycholic acid and glucocorticoid on the outcome of Kasai procedure: A systematic review and meta-analysis.

    Qiu JL, Shao MY, Xie WF, et al.

    Medicine 2018; (97(35)):e12005 doi:10.1097/MD.0000000000012005.

    PMID: 30170405
  8. 8

    Outcomes of late Kasai portoenterostomy in biliary atresia: a single-center experience.

    Khayat A, Alamri AM, Saadah OI

    The Journal of international medical research 2021; (49(5)):3000605211012596 doi:10.1177/03000605211012596.

    PMID: 33947263
  9. 9

    Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis.

    Huang L, Li S, Chen J, et al.

    PloS one 2023; (18(1)):e0280691 doi:10.1371/journal.pone.0280691.

    PMID: 36719881

This page is for informational purposes only and does not constitute medical advice about your baby's ursodiol or recovery. Follow your baby's hepatology team's instructions, and seek urgent care for fever, pale stools, worsening jaundice, or other warning signs.